Researcher profile
Adrian Chabowski
Affiliations
Organizations
Public evidence
10 connected articles
Short-Term Incubation of H9c2 Cardiomyocytes with Cannabigerol Attenuates Diacylglycerol Accumulation in Lipid Overload Conditions.2025 · Europe PMCConcentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media.2023 · PubMed Central Open AccessThe Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders.2022 · Europe PMCCannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity.2022 · Europe PMCPhytocannabinoids-A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment.2021 · Europe PMCAttenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity.2021 · PubMed Central Open AccessChronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.2020 · Europe PMCExperimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes.2020 · Europe PMCCan Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?2020 · Europe PMCPhytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.2020 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.